PKM and ovarian carcinoma: In addition, lncRNA H19 overexpression in ginsenoside 20(S)-Rg3-treated ovarian cancer cells increases glucose consumption, lactate production and pyruvate kinase isozyme M2 (PKM2) expression [34].